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Abstract
AIM
To determine if a standardized asthma severity scoring 
system (PASS) was associated with the time spent on 
continuous albuterol and length of stay in the pediatric 
intensive care unit (PICU). 
METHODS
This is a single center, retrospective chart review study at 
a major children’s hospital in an urban location. To qualify 
for this study, participants must have been admitted to 
the PICU with a diagnosis of status asthmaticus. There 
were a total of 188 participants between the ages of two 
and nineteen, excluding patients receiving antibiotics for 
pneumonia. PASS was calculated upon PICU admission. 
Subjects were put into one of three categories based on 
PASS: ≤ 7 (mild), 8-11 (moderate), and ≥ 12 (severe). 
The groups were compared based on different variables, 
including length of continuous albuterol and PICU stay.
RESULTS
The age distribution across all groups was similar. The 
median length of continuous albuterol was longest in 
the severe group with a duration of 21.5 h (11.5-27.5), 
compared to 15 (7.75-23.75) and 10 (5-15) in the 
moderate and mild groups, respectively (P  = 0.001). The 
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length of stay was longest in the severe group, with a 
stay of 35.6 h (22-49) compared to 26.5 (17-30) and 17.6 
(12-29) in the moderate and mild groups, respectively (P  
= 0.001). 
CONCLUSION
A higher PASS is associated with a longer time on con-
tinuous albuterol, an increased likelihood to require 
noninvasive ventilation, and a longer stay in the ICU. This 
may help safely distribute asthmatics to lower and higher 
levels of care in the future. 
Key words: Asthma; Noninvasive ventilation; Critical 
care; Albuterol
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Core tip: This is a single center retrospective study 
designed to determine whether or not the pediatric 
asthma severity score was associated with critical care 
interventions. It was found that patients with a higher 
(more severe) severity score were more likely to require 
continuous albuterol for longer (P  = 0.001) and were 
more likely to have a longer length of pediatric intensive 
care unit stay compared to those with less severe scores 
(P  = 0.001). It was also determined that patients with 
a higher severity score were more likely to require other 
critical care interventions, including noninvasive positive 
pressure ventilation and amiodarone. This may help safely 
distribute asthmatics to higher and lower levels of care in 
the future. 
Maue DK, Krupp N, Rowan CM. Pediatric asthma severity 
score is associated with critical care interventions. World J Clin 
Pediatr 2017; 6(1): 34-39  Available from: URL: http://www.
wjgnet.com/2219-2808/full/v6/i1/34.htm  DOI: http://dx.doi.
org/10.5409/wjcp.v6.i1.34
INTRODUCTION
Asthma is the one of the most common chronic pe­
diatric medical condition in the United States[1,2] and 
accounts for approximately 150000 hospitalizations 
per year[3,4]. It is estimated that upwards of 30% of 
pediatric emergency department visits due to asthma 
result in hospitalization[5]. A portion of these patients 
are admitted to the pediatric intensive care unit (PICU), 
although the rate of ICU admission varies widely by 
institution. A recent study in New Jersey showed that 
while admission rates for status asthmaticus are overall 
on the decline, there has been an increase in ICU 
admission for these patients from 4% in 1992 to 35% 
in 2006, which also led to an increase in cost to treat 
patients with status asthmaticus from 6.6 million in 
1992 to 9.5 million in 2006[6]. PICU admissions are very 
stressful for families[7] and are expensive. PICU beds 
can be limited, particularly during respiratory seasons. 
Hospital systems across the nation are making difficult 
decisions to triage those who truly are in need of critical 
care services, to optimize ICU bed availability for the 
sickest patients[8]. In making initial bed assignment 
decisions, however it is prudent to ensure that patients 
who are admitted to floor level care are unlikely to 
clinically decompensate after admission, thus requiring 
later ICU transfer. 
Asthma severity scores have been developed, vali­
dated, and used in various settings of pediatric care. The 
PASS (Pediatric Asthma Severity Score) was developed 
and validated in the early 2000’s[9,10]. In at least one 
study, the PASS was superior to spirometry at predicting 
the need for further treatment[10]. Severity scores have 
generally been used in the emergency department to help 
determine whether a patient requires hospital admission or 
can be safely discharged home[9­13]. However, there are no 
published studies to date that examine the effectiveness of 
a pediatric asthma scoring system in triage to ICU vs ward 
treatment.
The aim of this study is to determine whether the PASS 
is associated the length of continuous albuterol usage, 
and higher level respiratory support that often requires 
PICU level care. The hypothesis is that PASS symptom 
stratification (mild, moderate, or severe respiratory com­
promise) can be used to help identify patients most likely 
to require critical care interventions. 
MATERIALS AND METHODS
Approval for this study was obtained from the Indiana 
University institutional review board prior to data 
collection. This is a single center, retrospective chart re­
view of patients admitted to the PICU from July 2012­June 
2013 with an admitting diagnosis of status asthmaticus. 
Inclusion criteria were age two through nineteen years, 
admitted to Riley Hospital for Children PICU via the 
emergency department or direct admission to the 
PICU. Patients transferred from the ward or receiving 
antibiotics for bacterial pneumonia were excluded. The 
data was obtained from the electronic medical record 
system. Patients were identified based on those admitted 
to the PICU with the primary diagnosis code for status 
asthmaticus. Data points collected include: Demographics, 
medical history, admitting diagnosis, medications for 
asthma care (inpatient and outpatient), vital signs, level 
of respiratory support, clinical assessments by respiratory 
therapy, nursing and physicians, times of ICU admission, 
transfer, and medication changes. It was also noted 
whether patients were already followed in the Riley 
Hospital High Risk Asthma Clinic prior to admission, which 
is an intensive outpatient management program. Prior 
to data analysis, a time of greater than or less than 6 h 
of continuous albuterol was determined to be a collection 
point. This time frame was chosen as it seemed to be a 
reasonable time frame to attempt weaning of continuous 
albuterol in the emergency department or ward setting. 
PASS scores were calculated retrospectively at admission 
to the PICU, at the end of continuous bronchodilator 
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treatment, and at the first interval bronchodilator treat­
ment. The PASS calculation can be found in Table 1. 
This was accomplished by reviewing nursing vitals and 
respiratory therapy (RT) documentation. The first set of 
vitals and RT documentation after arrival to the PICU was 
used to calculate the admission score. The total length of 
time on continuous albuterol was calculated from charting 
on the medication administration record. The total length 
of time in the PICU was calculated from the first set of 
vitals charted by the PICU nurse to the time transfer 
orders were written. Groups were assigned as follows 
based on clinical guidelines utilized at other institutions 
for bronchodilator weaning: mild respiratory compromise 
were defined as PASS ≤ 7; moderate respiratory 
compromise PASS 8­11; severe respiratory compromise 
PASS ≥ 12[14]. 
Descriptive statistics using medians and interquartile 
ranges were calculated for continuous variables. Com­
parison of continuous variables between risk groups was 
done using Kruskal­Wallis test. Categorical variables were 
compared using χ 2 or fisher exact test where appropriate. 
Statistical significance was set at a value of 0.05. We used 
Statistical Package of the Social Science (SPSS) Statistical 
software for Windows, Version 20.0 (SPSS Inc., Chicago, 
IL, United States) and Microsoft Office Excel (Microsoft 
Corporation, Redmond, WA). 
RESULTS
Patient characteristics
A total of 188 subjects with the admission diagnosis 
of status asthmaticus were included in the study. The 
mean age at admission was 7.2 ± 4.0 years (range 
2­19 years). African American race and male gender 
accounted for the majority of the study population. 
Additional demographic information can be found in 
Table 2.
PASS ranges
In total, there were 40 subjects that fell into the mild 
respiratory compromise group, 117 in the moderate 
group, and 31 in the severe group. 
Respiratory support
The degree of respiratory support required for each 
patient was documented, specifically high flow nasal can­
nula, noninvasive positive pressure ventilation (NIPPV), 
intubation, and extracorporeal membrane oxygenation 
(ECMO). In total, 6 subjects required high flow nasal 
cannula, 6 required NIPPV, 1 was intubated, and none 
were on ECMO. The breakdown of the number in each 
group that required each form of respiratory support is 
found in Table 3. Not surprisingly, those in the severe 
group were more likely to receive NIPPV.
Medication usage
Medication use for the 188 patients as a whole and per 
group is displayed in Table 3. The severe respiratory 
compromise group was more likely to receive continuous 
albuterol for more than 6 h as well as aminophylline. The 
medium and high risk groups were more likely to receive 
scheduled ipratropium. There was no significant difference 
among the groups with terbutaline or magnesium sulfate. 
The difference is shown below in Table 4.
Table 1  Pediatric asthma severity score calculation table
Score 1 2 3
Respiratory rate
2 to 3 yr ≤ 34 35 to 39 ≥ 40
4 to 5 yr ≤ 30 31 to 35 ≥ 36
6 to 12 yr ≤ 26 27 to 30 ≥ 31
Older than 12 yr ≤ 23 24 to 27 ≥ 28
Oxygen > 90% on room air 85%-90% on room air < 85% on room air
requirements
Auscultation Normal breath sounds or end-expiratory 
wheeze only
Expiratory wheezing Inspiratory and expiratory wheezing or 
diminished breath sounds
Retractions  ≤ One site Two sites ≥ Three sites
Dyspnea Speaks in sentences, coos and babbles Speaks in partial sentences, short cry Speaks in single words/short phrases/grunting
Table 2  Demographic information
Characteristic Subgroup Total n  (%) Mild n  (%) Moderate n  (%) Severe n  (%) P  value
Gender Male 112 (59.6)    26 (65.0) 68 (58.1) 18 (58.1) 0.18
Female   76 (40.4)    14 (35.0) 49 (41.9) 13 (41.9)
Race/ethnicity Caucasian   44 (23.4)      5 (12.5) 29 (24.8) 10 (32.3) 0.18
African American 130 (69.1)    33 (82.5) 79 (67.5) 18 (58.1)
Hispanic 10 (5.3)    2 (5.0) 7 (6.0) 1 (3.2)
Other   4 (2.1) 0 (0) 2 (1.7) 2 (6.4)
Asthma history Uses controller medication 137 (72.9)    35 (87.5) 78 (66.7) 24 (77.4) 0.03
Patient in high risk asthma clinic   61 (32.4)    16 (40.0) 33 (28.2) 12 (38.7) 0.25
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Length of time on continuous albuterol
The moderate and severe group was on continuous 
albuterol longer. The mild group received continuous 
albuterol for a median of 10 h (IQR 5­15), moderate 
group for 15 h (IQR 7.75­23.75) and the severe group 
for 21.5 h (IQR 11.5 – 27.5) (P = 0.001). The difference 
among the groups is shown in Figure 1.
Total length of time in the pediatric ICU
The severe group was in the Pediatric ICU for a longer 
period of time. The mild group had a median length of 
stay of 17.6 h (IQR 13­29), the moderate group 26.5 h 
(17.3­39.4), and the severe group 35.6 h (22.2­49.6) 
(P = 0.001). The difference among the groups is demon­
strated in Figure 2.
DISCUSSION
To our knowledge, this is the first study that associates 
an asthma clinical severity score with PICU interventions 
and outcomes. Our high number of patients at a large 
pediatric hospital, recent study period, and common 
standard practices for status asthmaticus make the 
results generalizable to many children’s hospitals in the 
United States.
The most reassuring result of our study is the sig­
nificant difference among severity groups with regards to 
length of time on continuous albuterol and length of PICU 
stay. Based on these results, a patient’s admission PASS 
could help clinicians predict how long a patient could 
need ICU resources, and their risk of requiring intensive 
pharmacologic treatment such as aminophylline. Par­
ticularly in times of high utilization of critical care re­
sources, the ability to identify those that will not require 
continuous albuterol for extended periods of time and 
have a lower risk of requiring higher levels of respiratory 
support can be an exceedingly useful triage tool. Since 
the mild respiratory compromise group was less likely to 
receive prolonged continuous albuterol, it is feasible that 
these patients could be weaned to intermittent albuterol 
in the emergency room in a reasonable amount of time. 
The ability to objectively identify these patients during 
times of limited PICU bed availability can help ensure 
those that are likely to have the highest need for critical 
care obtain the resources first. This will not only improve 
patient safety but assist with patient flow through the 
emergency department. It may also assist accepting 
hospitals in triage of referred patients from outside 
facilities.
In this study, 99.5% of patients received systemic 
steroids, and there was no significant difference among 
the groups. It is also clear that magnesium sulfate is often 
used in asthmatics that are deemed critically ill, requiring 
PICU admission. Regardless of PASS score, there was no 
difference in this intervention when comparing severity 
groups. It is not particularly surprising that we did not see 
a significant difference in the use of most of medications 
among the different groups. Magnesium sulfate is com­
monly used at many institutions, including ours, in both 
the emergency department as well as the PICU. It has 
been shown to reduce bronchoconstriction and has been 
shown to help avoid hospitalization. The toxicity rates are 
also relatively low so it is considered safe to use[15].
There was a significant difference with aminophylline, 
with patients in the severe group more likely to receive 
it. At our institution, aminophylline use is restricted to the 
ICU setting, due to the potential for significant toxicity, and 
is reserved for patients with persistent respiratory distress 
despite other modalities. The fact that aminophylline 
use was seen only in the severe group base on PASS 
speaks to the congruence of the PASS to more subjective 
estimation of clinical status. The fact that the moderate 
group (PASS 8­11) had no aminophylline use at all during 
their clinical course is notable, in that the patients in this 
severity category did not decompensate to the point of 
requiring this particular intervention. Admittedly, there 
were only a total of four patients in the study that received 
aminophylline so it is difficult to make generalizations 
based on this data. The data on aminophylline is mixed 
with a recent study showing that, while it did improve lung 
Table 3  Medication usage by each severity group
Medication Total received all groups 
(%)
Mild compromise 
number received (%)
Moderate compromise 
number received (%)
Severe compromise 
number received (%)
P  value
Systemic steroids 187 (99.5)   40 (100) 116 (99.1) 31 (100)    0.737
Magnesium sulfate 126 (67.0) 26 (65)   77 (65.8)  23 (74.1)    0.646
Aminophylline   4 (2.1) 0 0    4 (12.9) < 0.001
Terbutaline   4 (2.1) 0   2 (1.7)  2 (6.5)     0.155
Scheduled ipratropium 146 (77.7)    21 (55.3) 100 (86.2)  25 (83.3) < 0.001
Continuous albuterol > 6 h 139 (73.9)    23 (57.5)   88 (75.2)  28 (90.3)    0.007
Total n (%) reported per severity group, P value obtained from extend fisher exact or χ 2 where appropriate. 
Table 4  Respiratory support required for each severity group
Respiratory support Mild Moderate Severe Pearson χ 2
High flow nasal cannula 1 (2.6) 4 (3.4) 1 (3.2) 0.96
Noninvasive positive 
pressure ventilation
0 2 (1.7) 4 (12.9) 0.003
Invasive mechanical 
ventilation
0 0 1(3.2) 0.078
Breakdown of respiratory support required in each severity group, total n 
(%) reported, P value obtained from extended fisher exact.
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function at six hours, there was no reduction in number 
of nebulized treatments as well as being inconclusive on 
whether or not it reduced length of stay or complications 
such as mechanical ventilation. There is also significant 
toxicity associated with aminophylline[16,17]. Therefore, 
most providers reserve it for patients who have a 
severe case when they are not responding to traditional 
treatments.
It is interesting that our study did not show any 
significant difference among the groups in terms of heated 
humidified high flow nasal cannula (HHFNC). This may 
be reflective of the trend to use HHFNC more commonly, 
even on general wards. It may also be due to the fact 
many patients on HHFNC were on it prior to arrival to 
the PICU, thus improving their work of breathing and 
improving their PASS. Recent studies have shown that 
when used correctly, HHFNC is safe to use on a general 
pediatric ward as long as there is a Pediatric ICU bed 
available should worsening respiratory failure or other 
complications ensue[18].
There are a few limitations with this study, mostly 
related to the retrospective nature of the study. Data 
sources to identify admission and discharge times and to 
calculate the PASS were consistent among all patients, 
which may mitigate some of the retrospective limitation. 
Another limitation is the lack of data surrounding PASS 
scores at arrival to the emergency department. As PASS is 
not a standard part of emergency department care at our 
institution, there was not enough detail in the retrospective 
charts to obtain this information uniformly for all patients. 
It is possible that some patients could have initially had a 
more severe PASS and then with treatment could have 
improved substantially before arriving to the PICU. Future 
studies will work to address this.
Our study finds that PASS ranges are associated with 
the use of critical care interventions. Patients that fall into 
the severe range were more likely to require a longer time 
on continuous albuterol as well as a longer time in the 
PICU. They were also more likely to require NIPPV as well 
as other medications typically reserved for severe status 
asthmaticus. Future prospective studies investigating 
PASS ranges as a triage tool would be needed to fully 
understand its utility in patients admitted to the hospital 
with asthma. 
COMMENTS
Background
Asthma is the most common chronic condition of childhood and status 
asthmaticus is a very frequent admitting diagnosis in the pediatric intensive care 
unit (PICU). These patients come to the PICU because it can be very serious 
and life threatening, and some patients are sicker than others. At the authors’ 
institution, the decision of whether or not to increase or decrease support is 
based on subjective exam of the patient. In previous studies, asthma severity 
scores have been studied in the ER as to whether or not they can predict if a 
patient needs to be admitted or safely discharged. In their study, we look at 
whether or not an asthma severity score (PASS, or Pediatric Asthma Severity 
Score) is predictive of the need for critical care services, specifically length of 
time on continuous albuterol and length of time in the PICU.
Research frontiers
There have been studies in the past looking at asthma severity scores and 
patient outcomes. Previous studies have mainly looked at using these scores in 
the emergency department and predicting whether or not a patient needs to be 
admitted or could be discharged. Healthcare is changing and many institutions 
are striving to standardize care, and using these scores could be another way 
to do so.
Innovations and breakthroughs
To their knowledge, this is the first study that has studied whether or not a 
patient’s asthma severity score (in this case, PASS) can be predictive of their 
need for critical care interventions. Their study found that if a patient fell into the 
severe group, he/she was more likely to be on continuous albuterol for longer 
and need the PICU longer. These patients were also more likely to require 
noninvasive positive pressure ventilation and be on aminophylline. 
Applications
This study could be applied in the future in multiple ways. It could be used to 
help PICU physicians predict which patients will need more intensive treatment 
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Figure 1  Length of time on continuous albuterol based on admission pediatric 
asthma severity score illustration of the difference in length of time on 
continuous albuterol among the three severity groups. The mild compromise 
group received continuous albuterol for 10 h (IQR: 5-15), moderate compromise 
group for 15 h (IQR: 7.75-23.75), and the severe compromise group for 21.5 h (IQR: 
11.5-27.5) (P = 0.001).
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Figure 2  Length of time in the intensive care unit based on admission pediatric 
asthma severity score. This figure shows the difference in length of time in the 
intensive care unit among the three severity groups. For the mild compromise group, 
the median length of time in the pediatric intensive care unit was 17.6 h (IQR: 13-29), 
moderate compromise group for 26.5 h, with a (IQR: 17.3-39.4), and the severe 
compromise group for 35.6 h (IQR: 22.2-49.6) (P = 0.001).
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or could safely have treatment de-escalated. It could also potentially be used 
to decide whether or not a patient needs PICU admission or could be safely 
treated on a general floor.
Terminology
PASS: Pediatric asthma severity score - a score that is determined by different 
variables (oxygen requirement, respiratory rate, work of breathing, retractions, 
auscultation) that “scores” how severe an asthma exacerbation is at that point 
in time.
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